Breast CancerDigital healthBehavioralCancerWomen's health
What this study is
This study aims to evaluate the use of mobile technology as a communication tool among patients with breast cancer and measured its effect on patient-reported cancer-related distress, specifically focusing on young women as they often face unique challenges.
What's being tested
- Mighty Pro Application
Intervention · OTHER
Access to Mighty Pro Application
Study details
- Sponsor
- Wake Forest University Health Sciences
- Conditions
- Breast Cancer · Cancer Distress
- Enrolling
- 120 people
- Starts
- 2026-09
- Est. completion
- 2030-01
- Design
- Open-label, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years – 45 YearsSex FEMALEHealthy volunteers Not acceptedYou may qualify if
- Ability to understand and willingness to sign an IRB-approved informed consent
- Age ≥ 18 and ≤ 45 years at the time of consent
- Female
- Established patient at Atrium Health Wake Forest Baptist Comprehensive Cancer Center (AHWFBCCC)
- Histological confirmation of any type and stage (0-IV) of breast cancer
- Screening (baseline) NCCN Distress Thermometer score ≥ 4
- Access to a mobile device for trial purposes and an active email address
- Ability to read and understand the English language. NOTE: The Mighty Pro Application is available in English only.
- As determined by the enrolling Investigator, ability of the participant to understand and comply with study procedures for the entire length of the study
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openAtrium Health Levine Cancer
Charlotte, North Carolina, United States
- Maggie Dzhanumova · Contact704-754-3768margarita.dzhanumova@advocatehealth.org
- Julie Fisher, MD · Principal investigator
Recruiting
Study team
Sponsor
Wake Forest University Health Sciences
Study ID IRB00119070
Principal investigator
Julie Fisher, MD
Wake Forest University Health Sciences
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.